Video

Comprehensive Cell Solutions Capacity Update May 2024: Cell & Gene Therapy

Source: Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises

Comprehensive Cell Solutions (CCS) is a CGT focused division of New York Blood Center Enterprises with a Draw-To-Thaw™ portfolio of CDMO services strategically located throughout the US built upon on NYBC’s 60+ years of experience.

Founded in 2003 as a business unit of New York Blood Center Enterprises, CCS offers its deep expertise in the development and manufacture of cell and gene therapies, using its GMP and GTP facilities. CCS provides a true vein-to-vein solution, spanning fresh cellular collections and cord blood-derived stem cells as source material, to cell isolation, manipulation and cryopreservation capabilities for preclinical to commercial stage products.

CCS boasts a client roster comprised of the world’s leading pharmaceutical companies, innovative biotechnology organizations, and academic medical centers. CCS maintains its headquarters in New York City, where it offers its full service CDMO capabilities from cellular collections and clinical apheresis through manufacturing and cryopreservation. Additional collection suites, apheresis services, and development and manufacturing operations are offered at sites in Providence, RI, Kansas City, MO, St. Paul, MN, Houston, TX and Louisville, KY.

access the Video!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises